🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Gurraacha › Maryland

Qorannoo klinikaalii Kansarii Gurraacha Maryland keessatti

Qorannoo 8 Kansarii Gurraacha f Maryland keessatti hirmaatuu jiru.

Takkalaa qorannoo (Ingiliffa)

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

  • National Cancer Institute (NCI), Bethesda
  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
4 Weeks – 99 Years · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT00040352

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  • National Cancer Institute, Bethesda
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT05727904

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

  • US Dermatology Partners DBA DermAssociates, PC, Rockville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06585410

A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 72 · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT02621021

Integrated Cancer Repository for Cancer Research

  • Northwest Hospital, Randallstown
  • William E. Kahlert Regional Cancer Center, Westminster
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 19 hanga 110 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT02012699

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

  • Frederick Health Hospital, Frederick
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT07327489

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

  • National Cancer Institute, Bethesda
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Bit-2026 · NCT06171750

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Baltimore
  • Massive Bio SYNERGY-AI site, Bethesda
  • Massive Bio SYNERGY-AI site, Silver Spring
  • fi 1 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.